Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients | NEJM - nejm.org
- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients | NEJM nejm.org
- Here's an Alternative to Statins for Lowering Cholesterol TIME
- ACC 2023 – Esperion’s outcomes win looks lacklustre Evaluate Pharma
- New cholesterol pill, Nexletol, lowers heart attack risk for patients who can't take statins: study Fox News
- Esperion's statin alternative is shown to cut heart attacks - STAT STAT
- View Full Coverage on Google News